Usefulness of salivary trans-3′-hydroxycotinine concentration and trans-3′-hydroxycotinine/cotinine ratio as biomarkers of cigarette smoke in pregnant women

Journal of Analytical Toxicology

Volumn 29, Issue 7, 2005, Pages 689-695

  Kim, Insook ^a   Wtsadik, Abraham ^a   Choo, Robin E ^a   Jones, Hendrée E ^b,c   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' HYDROXYCOTININE; BIOLOGICAL MARKER; CIGARETTE SMOKE; COTININE; NICOTINE;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GAS CHROMATOGRAPHY; HUMAN; ION MONITORING; MASS SPECTROMETRY; PREGNANT WOMAN; SALIVA ANALYSIS; SALIVA LEVEL; SMOKING; SOLID PHASE EXTRACTION; TRANS ISOMER;

NICOTIANA TABACUM;

EID: 29144433374     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/29.7.689     Document Type: Article

References (32)

1. J.C. Kleinman, M.B. Pierre, Jr., J.H. Madans, G.H. Land, and W.F. Schramm. The effects of maternal smoking on fetal and infant mortality. Am. J. Epidemiol. 127: 274-282 (1988).
2. K.O. Haustein. Cigarette smoking, nicotine and pregnancy. Int. J. Clin. Pharmacol. Ther. 37: 417-427 (1999).
3. NIDA. NIDA survery provides first national data on drug use during pregnancy. NIDA Notes 10: (1995).
4. T.J. Mathews. Smoking during pregnancy in the 1990s. Natl. Vital Stat. Rep. 49: 1-14 (2001).
5. N.R. Boyd, R.A. Windsor, L.L. Perkins, and J.B. Lowe. Quality of measurement of smoking status by self-report and saliva cotinine among pregnant women. Matern. Child Health 2: 77-83 (1998).
6. R. Lindqvist, L. Lendahls, O. Tollbom, H. Aberg, and A. Hakansson. Smoking during pregnancy: comparison of self-reports and cotinine levels in 496 women. Acta Obstet. Gynecol. Scand. 81: 240-244 (2002).
7. N.L. Benowitz. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol. Rev. 18: 188-204 (1996).
8. L. Owen and A. McNeill. Saliva cotinine as indicator of cigarette smoking in pregnant women. Addiction 96: 1001-1006 (2001).
9. M.J. Jarvis, M.A. Russell, N.L. Benowitz, and C. Feyerabend. Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure. Am. J. Public Health 78: 696-698 (1988).
10. M. Onuki, K. Yokoyama, K. Kimura, H. Sato, R.B. Nordin, L. Naing, Y. Morita, T. Sakai, Y. Kobayashi, and S. Araki. Assessment of urinary cotinine as a marker of nicotine absorption from tobacco leaves: a study on tobacco farmers in Malaysia. J. Occup. Health 45: 140-145 (2003).
11. M. Page-Sharp, T.W. Hale, L.P. Hackett, J.H. Kristensen, and K.F. Ilett. Measurement of nicotine and cotinine in human milk by high-performance liquid chromatography with ultraviolet absorbance detection. J. Chromatogr. B 796: 173-180 (2003).
12. N.L. Benowitz and P. Jacob, III. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin. Pharmacol. Ther. 56: 483-493 (1994).
13. G.B. Neurath, M. Dunger, D. Orth, and F.G. Pein. trans-3′- Hydroxycotinine as a main metabolite in urine of smokers. Int. Arch. Occup. Environ. Health 59: 199-201 (1987).
14. G.A. Kyerematen and E.S. Vesell. Metabolism of nicotine. Drug Metab. Rev. 23: 3-41 (1991).
15. N.L. Benowitz, P. Jacob, III, I. Fong, and S. Gupta. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J. Pharmacol. Exp. Ther. 268: 296-303 (1994).
16. N.L. Benowitz and P. Jacob, III. trans-3′-Hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smoking. Br. J. Clin. Pharmacol. 51: 53-59 (2001).
17. D. Dempsey, P. Jacob, III, and N.L. Benowitz. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J. Pharmacol. Exp. Ther. 301: 594-598 (2002).
18. M. Rebagliato, F. Bolumar, V. Florey Cdu, M.J. Jarvis, S. Perez-Hoyos, I. Hernandez-Aguado, and M.J. Avino. Variations in cotinine levels in smokers during and after pregnancy. Am. J. Obstet. Gynecol. 178: 568-571 (1998).
19. L.N. Wright, J.M. Thorp, Jr., J.A. Kuller, R.P. Shrewsbury, C. Ananth, and K. Hartmann. Transdermal nicotine replacement in pregnancy: maternal pharmacokinetics and fetal effects. Am. J. Obstet. Gynecol. 176: 1090-1094 (1997).
20. J. Klein, P. Blanchette, and G. Koren. Assessing nicotine metabolism in pregnancy - a novel approach using hair analysis. Forensic Sci. Int. 145: 191-194 (2004).
21. M. Curvall, C.E. Elwin, E. Kazemi-Vala, C. Warholm, and C.R. Enzell. The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers. Eur. J. Clin. Pharmacol. 38: 281-287 (1990).
22. S. Zevin, P. Jacob, P. Geppetti, and N.L. Benowitz. Clinical pharmacology of oral cotinine. Drug Alcohol Depend. 60: 13-18 (2000).
23. R.E. Choo, M.A. Huestis, J.R. Schroeder, A.S. Shin, and H.E. Jones. Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug Alcohol Depend. 75: 253-260 (2004).
24. I. Kim, W.D. Darwin, and M.A. Huestis. Simultaneous determination of nicotine, cotinine, norcotinine, and trans-3′-hydroxycotinine in human oral fluid using solid phase extraction and gas chromatography-mass spectrometry. J. Chromatogr. B 814: 233-240 (2005).
25. J.F. Etter, T. Vu Duc, and T.V. Perneger. Saliva cotinine levels in smokers and nonsmokers. Am. J. Epidemiol. 151: 251-258 (2000).
26. M.C. Bentley, M. Abrar, M. Kelk, J. Cook, and K. Phillips. Validation of an assay for the determination of cotinine and 3-hydroxycotinine in human saliva using automated solid-phase extraction and liquid chromatography with tandem mass spectrometric detection. J. Chromatogr. B 723: 185-194 (1999).
27. R.A. Etzel. A review of the use of saliva cotinine as a marker of tobacco smoke exposure. Prev. Med. 19: 190-197 (1990).
28. D. Dempsey, P. Tutka, P. Jacob, III, F. Allen, K. Schoedel, R.F. Tyndale, and N.L. Benowitz. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin. Pharmacol. Ther. 76: 64-72 (2004).
29. R.A. Davis and M. Curvall. Determination of nicotine and its metabolites in biological fluids: in vivo studies. In Analytical Determination of Nicotine and Related Compounds and Their Metabolites, J.W. Gorrod and P. Jacob, III, Eds. Elsevier Science B.V., Amsterdam, The Netherlands, 1999, pp 583-643.
30. P. Zuccaro, I. Altieri, M. Rosa, A.R. Passa, S. Pichini, G. Ricciarello, and R. Pacifici. Determination of nicotine and four metabolites in the serum of smokers by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. 621: 257-261 (1993).
31. M. Meger, I. Meger-Kossien, A. Schuler-Metz, D. Janket, and G. Scherer. Simultaneous determination of nicotine and eight nicotine metabolites in urine of smokers using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 778: 251-261 (2002).
32. G.B. Neurath. Aspects of the oxidative metabolism of nicotine. Clin. Investig. 72: 190-195 (1994).